Refine your search
Collections
Co-Authors
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Elango, K.
- Design, Development and Evaluation of Pulsatile Drug Delivery System of Ramipril
Abstract Views :198 |
PDF Views:0
Authors
Affiliations
1 Department of Pharmaceutics, College of Pharmacy, Madras Medical College, Chennai-03, IN
1 Department of Pharmaceutics, College of Pharmacy, Madras Medical College, Chennai-03, IN
Source
Research Journal of Pharmaceutical Dosage Form and Technology, Vol 6, No 4 (2014), Pagination: 235-242Abstract
The aim of the present investigation is to develop a Ramipril pulsatile drug delivery system. Pulsincap is based on an insoluble capsule body filled with Ramipril Egg albumin microspheres and cap filled with uncoated granules, separated by HPMC K4M plug. Ramipril microspheres were prepared by emulsion polymerization method with egg Albumin by varying drug to polymer ratio (1:1, 1:2, 1:3and 1:4). Granules were prepared by wet granulation method by varying concentration of superdisintegrant. Optimized microspheres were evaluated for the interaction study by FT-IR, percentage yield, angle of repose, drug content, SEM and particle size analysis. Optimized granules were evaluated for various parameters like angle of repose, carr's index and drug content. The formaldehyde treated capsule bodies were tested for physical appearance, visual defects, solubility studies and qualitative chemical test for free formaldehyde. The optimized Ramipril loaded pulsincap were evaluated for in vitro drug release and kinetic study. The drug release from optimized Ramipril pulsincap followed Zero order kinetics and mechanism of drug release was governed by peppas - korsmeyer model. Ramipril microspheres with small particle size, good loading capacity are produced by M4 formulation. G4 showed better release profile. Thus optimized formulation were formulated as pulsincap and showed in vitro release up to 24 hours.Keywords
Pulsatile Drug Delivery, Formaldehyde Treated Capsules, Microspheres, Egg Albumin.- Formulation Development and Evaluation of Bilayer Tablets of Telmisartan for Immediate Release and Metformin Hydrochloride for Sustained Release
Abstract Views :190 |
PDF Views:0
Authors
Affiliations
1 Department of Pharmaceutics, College of Pharmacy, Madras Medical College, Chennai-600003, Tamil Nadu, IN
1 Department of Pharmaceutics, College of Pharmacy, Madras Medical College, Chennai-600003, Tamil Nadu, IN
Source
Research Journal of Pharmaceutical Dosage Form and Technology, Vol 5, No 3 (2013), Pagination: 139-144Abstract
The aim of the study was to design bilayer tablets containing Telmisartan for immediate release and Metformin hydrochloride for sustained release. Telmisartan has the strongest binding affinity to AT1 receptor among various ARBs and also has positive effects on insulin resistance syndrome because of the partial agonistic activity towards peroxisome proliferator-activated receptor-gamma (PPARγ). Metformin is an antihyperglycemic not a hypoglycemic. Combinations of both drugs effect the treatment of hypertension in Type-II diabetes mellitus patients and improve the patient compliance. Telmisartan belongs to class II drug in BCS classification. Enhancement of solubility of Telmisartan was observed with physical mixture of drug with beta (β)-Cyclodextrin. Immediate release layers were prepared by wet granulation method using various concentration of sodium starch glycolate as superdisintegrant. SR layers were prepared by wet granulation method using swellable polymer HPMC K4 M and HPMC K100 M in different ratios. Both Immediate (L1, L2 and L3) and Sustained release (F1, F2, F3, F4 and F5) tablets were formulated and evaluated. All the values were found to be satisfactory and were within limits. From the results obtained I3 and S5 were selected and finally compressed into bilayer tablets. In vitro release studies were carried out using USP type II paddle apparatus in 0.1M HCl for first 2 hours and pH 6.8 phosphate buffer solution for next 8 hours as dissolution medium. Stability studies were carried out at 40 ± 2°c and 75±5% RH for a period of three months.Keywords
Telmisartan, Metformin Hydrochloride, Bilayer Tablet, Wet Granulation.- Preparation, Characterization and Anti-Inflammatory Activity of Chitosan Stabilized Silver Nanoparticles
Abstract Views :217 |
PDF Views:0
Authors
Affiliations
1 Department of Pharmaceutics, College of Pharmacy, Madras Medical College, Chennai-03, IN
1 Department of Pharmaceutics, College of Pharmacy, Madras Medical College, Chennai-03, IN